215878-20-9

Basic information

• Product Name: 3-(4-PIPERIDINYL)-1,3-BENZOXAZOL-2(3H)-ONE
• Synonyms: 3-(4-PIPERIDINYL)-1,3-BENZOXAZOL-2(3H)-ONE;3-(piperidin-4-yl)benzo[d]oxazol-2(3H)-one;3-(4-piperidinyl)-2(3H)-Benzoxazolone;-1,3-benzoxazol-2(3H);3-(4-Piperidinyl)
• CAS NO: 215878-20-9
• Molecular Formula: C₁₂H₁₄N₂O₂
• Molecular Weight: 218.26
• Mol File: 215878-20-9.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 355.8°C at 760 mmHg
• Flash Point: 169°C
• Appearance: /
• Density: 1.259g/cm³
• Vapor Pressure: 3.05E-05mmHg at 25°C
• Refractive Index: 1.596
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 3-(4-PIPERIDINYL)-1,3-BENZOXAZOL-2(3H)-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-PIPERIDINYL)-1,3-BENZOXAZOL-2(3H)-ONE(215878-20-9)
• EPA Substance Registry System: 3-(4-PIPERIDINYL)-1,3-BENZOXAZOL-2(3H)-ONE(215878-20-9)

Safety Data

• Hazardous Substances Data: 215878-20-9(Hazardous Substances Data)

Usage

General Description

3-(4-piperidinyl)-1,3-benzoxazol-2(3H)-one is a chemical compound with a molecular formula of C15H16N2O2. 3-(4-PIPERIDINYL)-1,3-BENZOXAZOL-2(3H)-ONE is a benzoxazolone derivative and contains a piperidine ring. It is commonly used as a building block in the synthesis of pharmaceutical and agrochemical compounds. The compound has also been studied for its potential biological activity, including its role as a serotonin receptor antagonist. Its precise applications and potential uses are still under investigation and exploration by researchers in the field of chemistry and pharmaceutical science.

InChI:InChI=1/C12H14N2O2/c15-12-14(9-5-7-13-8-6-9)10-3-1-2-4-11(10)16-12/h1-4,9,13H,5-8H2

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 95-55-6 2-amino-phenol 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 162045-48-9 1-(tert-butoxycarbonyl)-4-[(2-hydroxyphenyl)amino]piperidine 
• 162045-53-6 tert-butyl-4-(2-oxobenzo[d]oxazole-3-(2H)-yl)piperidin-1-carboxylate 

Downstream Products

• 204696-88-8 1-[N²-[N-[[4-[2(3H)-oxobenzoxazol-3-yl]-1-piperidinyl]carbonyl]-3,5-dibromo-D-tyrosyl]-N⁶-(1,1-dimethylethoxycarbonyl)-L-lysyl]-4-(4-pyridinyl)-piperazine 
• 400797-17-3 3-(1-{3-[5-Acetyl-3-(4-bromo-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxy-propyl}-piperidin-4-yl)-3H-benzooxazol-2-one 
• 173842-04-1 5-Chloro-1,1-dioxido-2-(4-(4-(2-oxo-3-benzoxazolinyl)-piperidin-1-yl)-butyl)-1,2-benzisothiazol-3(2H)-one 

Relevant articles and documents

HETEROCYCLIC COMPOUND, APPLICATION THEREOF, AND COMPOSITION CONTAINING SAME

A heterocyclic compound represented by formula XI, a pharmaceutically acceptable salt, a solvate, or a solvate of a pharmaceutically acceptable salt thereof, use thereof, and a composition containing the same. The compound is novel in structure and has good STAT5 inhibitory activity.

Piperidine amides as 11β-hydroxysteroid dehydrogenase type 1 inhibitors

A series of piperidine amide inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) were identified via modifications of the HTS hit compound 1. The synthesis, in vitro biological evaluation, and structure-activity relationship of these co

Design and synthesis of N-alkylated saccharins as selective α-1a adrenergic receptor antagonists

Benign prostatic hyperplasia can be managed pharmacologically with α-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the α-la receptor subtype may offer advantages in clinical applications with respect to hypotensive side effect